Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Upadacitinib effectively treats psoriasis and lichen planus together.

Antibiotics can reduce acne but may lead to resistant bacteria, and understanding the skin's bacteria is important for treatment.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

People with hidradenitis suppurativa have a higher risk of kidney stones.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Type I interferons play a key role in the development of various skin diseases.

Apremilast did not work for treating severe alopecia areata.

Dupilumab helps children with alopecia areata regrow hair safely.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Combining fire needle therapy with doxycycline improves severe acne more than doxycycline alone.